Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT). [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO5093151 in patients with primary open-angle glaucoma o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• RO5093151

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Glaucoma | Phase 1 | Status: COMPLETED